Scancell Issuing 20.4M ADSs (204.1M Consideration Shares) Representing 13.7% Of Enlarged Share Capital; Neuphoria Stockholders To Also Receive CVRs Linked To Milestones

Loading news article.

Scancell Issuing 20.4M ADSs (204.1M Consideration Shares) Representing 13.7% Of Enlarged Share Capital; Neuphoria Stockholders To Also Receive CVRs Linked To Milestones | WAPE

Scancell Issuing 20.4M ADSs (204.1M Consideration Shares) Representing 13.7% Of Enlarged Share Capital; Neuphoria Stockholders To Also Receive CVRs Linked To Milestones

Article summary

Related companies

Comments —